-
Lombardi Gala Celebrates Its Founder’s Legacy
The 32nd Annual Lombardi Gala was dedicated to the memory of Margaret Hodges, who helped found the event, and honored DeMaurice “De” Smith of the NFL Players Association and former NFL player Mark Rypien for their philanthropic work on behalf of cancer research, as well as Filipa Lynce, MD, for excellence as an early career scientist at Georgetown Lombardi.
Category: Lombardi Stories
-
Obese Mice Lose a Third of Their Fat Using a Natural Protein
A Georgetown University-led study investigating a protein for its possible role in cancer has instead found it to be a powerful regulator of metabolism.
Category: News Release
-
More Clues Revealed in Link Between Normal Breast Changes and Invasive Breast Cancer
A research team led by investigators from Georgetown Lombardi Comprehensive Cancer Center has published the results of a mouse study that shows how changes in mammary glands to accommodate breastfeeding use a molecular process believed to contribute to the survival of premalignant breast cells.
Category: News Release
-
Mouse Study Mirrors Human Findings That Link Chemotherapy and APOE4 to Cognitive Issues
New research by Georgetown University Medical Center investigators indicates that a chemotherapy drug commonly used to treat breast cancer alters brain structure and function in mice that express the human APOE4 gene, which is known to significantly increase the risk of developing Alzheimer’s disease.
Category: News Release
-
First Large Study Details Cognitive Outcomes Among Older Breast Cancer Patients
The first large U.S. study of cognition in older breast cancer patients, led by researchers from Georgetown Lombardi Comprehensive Cancer Center, indicates that within the first two years after diagnosis and treatment, most women do not experience cancer-related cognitive problems.
Category: News Release
-
Nobel Prize-Winning Science is Key to New Treatments for Cancer
The science that earned two researchers the Nobel Prize in Physiology or Medicine for 2018 — the discovery of cancer therapy by inhibition of negative immune regulation — is at the heart of an increasing number of standard treatments and many ongoing clinical trials at Georgetown Lombardi Comprehensive Cancer Center.
Category: News Release
-
Animal Study Suggests Deep Space Travel May Significantly Damage GI Function in Astronauts
Simulations with animal models meant to mirror galactic cosmic radiation exposure to astronauts are raising red flags for investigators at Georgetown University Medical Center about the health of astronauts during long voyages, such as to Mars.
Category: News Release
-
Georgetown University Medical Center Names Subha Madhavan As Chief Data Scientist
Georgetown University Medical Center has named Subha Madhavan, PhD, as its Chief Data Scientist and director of its newly established Office for Health Data Science and Informatics.
Category: News Release
-
ACA Expansion Did Not Improve Access to Complex Surgeries for Low-Income/Minority Patients
A new study published by a team led by Georgetown University Medical Center researchers finds that despite expectations following the Affordable Care Act (ACA)’s Medicaid expansion, there was no increased use of complex surgical procedures at high volume hospitals among ethnic/racial minorities and low-income populations.
Category: News Release
-
Georgetown Lombardi Summer Program Cultivates Young Scientists
High school and college students participating in the Summer Research Volunteer Program at Georgetown Lombardi Comprehensive Cancer Center gained valuable insights about the process of scientific discovery and the biology of cancer.
Category: Lombardi Stories
